期刊文献+

慢性乙型肝炎抗病毒治疗中护理干预模式的可行性分析 被引量:8

Feasibility study of anti-virus therapeutic nursing intervention mode of chronic hepatitis B patients
原文传递
导出
摘要 目的研究护理干预对慢性乙型肝炎患者抗病毒治疗依从性的影响,探讨护理干预模式的可行性与效果。方法将61例使用干扰素和(或)拉米夫定抗病毒治疗的慢性乙型肝患者分为试验组(A组,n=31)和对照组(B组,n=30)。试验组实施一系列护理干预,对照组不予以干预,两组患者均于疗程结束后进行遵医行为调查。结果试验组74.14%患者能完全遵医,完成疗程28例,占90.32%;对照组63.33%患者能完全遵医,完成疗程23例,占76.67%。结论护理干预可对提高慢性乙型肝炎患者抗病毒治疗的依从性,切实有效可行。 Objective To study influence of anti-virus therapeutic compliance of chronic hepatitis B patient with nursing intervention,explore feasibility and result of intervention mode. Methods The chronic hepatitis B padent treanted by IFN and(or) lamivudinc were divided into test group(A, n = 31 ) and contrast (B, n = 30). The test group was carricd out a series of nursing intervention, and the control group was not, two groups was investigated af- ter treatment. Results 74.14% patients in test group obeyed the instruction completely, 28 cases(90.32 % ) patients completed the course of treatment. 63.33 % patients in contrast group obeyed the instruction completely. 23 cases(76.67 % ) patients completed the treatment. Conclusion It has sufficient reasons and is feasible and effective that anti-virus therapeutic compliance of chronic hepatitis B patient is elevated by nursing intervention.
出处 《中国基层医药》 CAS 2006年第2期301-302,共2页 Chinese Journal of Primary Medicine and Pharmacy
基金 广东省惠州市科技计划项目(y200503)
关键词 肝炎 乙型 慢性 护理干预 拉米夫定 干扰素 慢性乙型肝炎 抗病毒治疗 Hepatitis B, chronic Nursing intervention Lamivudinc Interferon
  • 相关文献

参考文献7

二级参考文献25

  • 1周达生,姚华庭.医学系统工程与遵医行为研究[J].中国医院管理,1995,15(2):37-39. 被引量:583
  • 2第五次全国传染病与寄生虫病学术会议纪要[J].中华传染病杂志,1995,13(4):238-240. 被引量:25
  • 3张丽华,刘兆昶,王作江,尹建梅,王霁云.糖尿病的健康教育及其效果评价[J].中国慢性病预防与控制,1995,3(4):170-171. 被引量:48
  • 4邸国勋.糖尿病的治疗[J].实用内科杂志,1991,11(12):620-620.
  • 5戴志澄 祁国明 等.乙肝病毒性肝炎的流行特征,中国病毒性肝炎血清流行病学调查1992-1995[M].北京:科学技术文献出版社,1997.39-59.
  • 6Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
  • 7Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
  • 8Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
  • 9Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
  • 10Diepolder HM;Jung MC;Keller E.A vigorous virus-specific CD-4 T cell response may contribute to the association of HLADR13 with viral clearance in hepatitis B[J],1998.

共引文献14290

同被引文献62

引证文献8

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部